Takeda
|
4,275.00 |
|
16.00 |
0.38% |
4.55% |
2025-04-25 |
AbbVie
|
180.79 |
|
3.57 |
2.01% |
8.13% |
2025-04-24 |
Agios Pharmaceuticals
|
29.26 |
|
0.89 |
3.14% |
-7.61% |
2025-04-24 |
ALKERMES
|
27.67 |
|
0.52 |
1.92% |
13.22% |
2025-04-24 |
Amgen
|
279.88 |
|
1.77 |
0.64% |
3.88% |
2025-04-24 |
Biogen
|
119.47 |
|
1.23 |
1.04% |
-40.89% |
2025-04-24 |
BioMarin Pharmaceutical
|
62.74 |
|
0.80 |
1.29% |
-23.65% |
2025-04-24 |
Bristol-Myers Squibb
|
48.67 |
|
0.11 |
0.23% |
8.78% |
2025-04-24 |
Exelixis
|
37.21 |
|
0.43 |
1.17% |
58.14% |
2025-04-24 |
Genmab
|
1,343.00 |
|
3.00 |
0.22% |
-31.29% |
2025-04-25 |
Gilead Sciences
|
106.03 |
|
-0.44 |
-0.41% |
62.50% |
2025-04-24 |
GlaxoSmithKline
|
1,387.50 |
|
-6.50 |
-0.47% |
-16.06% |
2025-04-25 |
Glaxosmithkline
|
37.50 |
|
0.47 |
1.27% |
-8.34% |
2025-04-24 |
Incyte
|
58.95 |
|
0.95 |
1.64% |
15.24% |
2025-04-24 |
Ionis Pharmaceuticals
|
29.54 |
|
0.44 |
1.51% |
-29.40% |
2025-04-24 |
J&J
|
154.85 |
|
-0.55 |
-0.35% |
5.45% |
2025-04-24 |
Eli Lilly
|
861.30 |
|
30.47 |
3.67% |
18.92% |
2025-04-24 |
Merck
|
79.95 |
|
1.27 |
1.61% |
-38.80% |
2025-04-24 |
Moderna
|
27.35 |
|
0.82 |
3.07% |
-74.26% |
2025-04-24 |
Neurocrine Biosciences
|
105.75 |
|
2.53 |
2.45% |
-23.24% |
2025-04-24 |
Novartis
|
92.55 |
|
0.55 |
0.60% |
3.41% |
2025-04-25 |
Novartis
|
111.17 |
|
1.15 |
1.05% |
12.14% |
2025-04-24 |
Pfizer
|
22.81 |
|
0.43 |
1.92% |
-9.81% |
2025-04-24 |
PTC Therapeutics
|
49.54 |
|
-0.41 |
-0.82% |
94.35% |
2025-04-24 |
Ultragenyx Pharmaceutical
|
37.62 |
|
0.31 |
0.83% |
-14.21% |
2025-04-24 |
Regeneron Pharmaceuticals
|
599.21 |
|
11.26 |
1.92% |
-32.69% |
2025-04-24 |
Roche Holding
|
260.95 |
|
-1.35 |
-0.51% |
18.08% |
2025-04-25 |
Sanofi
|
92.93 |
|
-0.42 |
-0.45% |
1.86% |
2025-04-25 |
Sarepta Therapeutics
|
61.81 |
|
2.32 |
3.90% |
-51.48% |
2025-04-24 |
Teva Pharmaceutical Industries
|
5,227.00 |
|
-73.00 |
-1.38% |
5.96% |
2025-04-24 |
Vertex Pharmaceuticals
|
492.96 |
|
0.21 |
0.04% |
23.95% |
2025-04-24 |